Mucus adhesion drug delivery
OwnerYimin Suninventor
Life of this patent
Estimating the term…
Loading patent…
OwnerYimin Suninventor
Estimating the term…
The present invention relates to a mucus adhesion drug delivery technology. The technology involves the preparation of materials consisting of mucus adhesive excipient polymer chemically bonded with drug molecules and delivery of the materials with fast disintegration tablet with enteric coating to intestine. The bonding between the excipient polymer and the drug molecules is either ionic bonds, covalent bonds, or metal coordination bonds. The test of the mucus adhesion drug delivery technology was carried out using a dog model. The test data indicated successful retaining of drug molecules on the intestine mucus resulting in not only dramatic extension of drug release time, but also great improvement in the bioavailability of the API.
A composition comprising an effective amount of a biologically active agent bonded with a mucoadhesive polymer ionically or covalently or via metal coordination bonding, whereby after the composition is administered to a subject, the biologically active agent exerts its pharmaceutical effect while retaining on mucus of the animal.
Dependencies are inferred from the claim text.